Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Oct 13, 2026

PRME — Prime Medicine, Inc. Dilution Risk Tracker

Track PRME dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PRME — Get alerts when the score changes →

As of October 13, 2026, Prime Medicine, Inc. (PRME) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Prime Medicine, Inc. has a market capitalization of $654.77M, 181.38M shares outstanding, 194 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
95
📊 Float Risk
42
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 34%
💰 Capital Raise model 55%
• Critical: only 2.8 months cash remaining
🔄 Reverse Split model est. 15%
• Only 3 months cash — financial pressure
📉 Score Deterioration model 10%
• Score in HIGH risk zone (65/100)
🔔 Track PRME — Get forecast alerts →

Market Data

Market Cap$654.77M
Shares Outstanding181.38M
Float108.73M
Cash$47.45M
Debt$114.51M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore65/100DilutionWatch score record
Shares Outstanding181.38MVerified float table or market cache
Public Float108.73MVerified float table or market cache
Market Cap$654.77MMarket data cache
Cash Runway2.8 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 3, EFFECT 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 7.4% shares (2026Q1 vs prior)
194 institutional holders · 112.26M shares
#1 Alphabet Inc. 16.56M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 8.95M shares
#3 BlackRock, Inc. 8.50M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest32.12M
Days to Cover8.4
% of Float29.5%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-03
xbrl XBRL CONVERTIBLE 2024-03-01
EFFECT EFFECT 2026-03-04
4 INSIDER TRANSACTION 2026-02-27
4 INSIDER TRANSACTION 2026-02-24
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual PRME Dilution Snapshot

Prime Medicine, Inc. (PRME) has a DilutionScore of 65/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

PRME's DilutionScore is currently 65/100 (High risk), with 3 score changes tracked over 89 days. The score improved from 57/100 (High risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202665/100HIGH53 days
Aug 14 – Aug 21, 202657/100HIGH7 days
Jul 17 – Aug 13, 202662/100HIGH28 days
Jul 16, 202661/100HIGH1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

PRME shares outstanding have increased 0.1% from 180.51M (Mar 2026) to 180.62M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 16, 2026180.62M108.73M▲ 1.31%
May 09, 2026180.62M107.32M▲ 2.00%
May 02, 2026180.62M105.22M▲ 0.03%
Apr 11, 2026180.55M105.20M▲ 0.78%
Mar 07, 2026180.51M104.38M▲ 0.02%
Mar 05, 2026180.51M104.37M▼ 1.92%
Mar 04, 2026180.51M106.41M▲ 1.98%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track PRME Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment PRME files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking PRME — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PRME
PRME FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.